KR20100101303A - Specific protein domain for the detection of salmonella contamination and manufacture method of its antibody and immuno-fluorescent psq nanoparticle - Google Patents
Specific protein domain for the detection of salmonella contamination and manufacture method of its antibody and immuno-fluorescent psq nanoparticle Download PDFInfo
- Publication number
- KR20100101303A KR20100101303A KR1020090019720A KR20090019720A KR20100101303A KR 20100101303 A KR20100101303 A KR 20100101303A KR 1020090019720 A KR1020090019720 A KR 1020090019720A KR 20090019720 A KR20090019720 A KR 20090019720A KR 20100101303 A KR20100101303 A KR 20100101303A
- Authority
- KR
- South Korea
- Prior art keywords
- antibody
- psq
- salmonella
- nanoparticle
- fluorescent
- Prior art date
Links
- 241000607142 Salmonella Species 0.000 title claims abstract description 21
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 17
- 238000004519 manufacturing process Methods 0.000 title abstract description 7
- 238000000034 method Methods 0.000 title description 11
- 238000001514 detection method Methods 0.000 title description 10
- 238000011109 contamination Methods 0.000 title 1
- 108020001580 protein domains Proteins 0.000 title 1
- 108700017341 Salmonella HilA Proteins 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 abstract description 9
- 238000009739 binding Methods 0.000 abstract description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 244000000010 microbial pathogen Species 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108010040721 Flagellin Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000016784 immunoglobulin production Effects 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 3
- 241000186779 Listeria monocytogenes Species 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000602423 Vibrio cholerae O1 Species 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000011091 antibody purification Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- NKSJNEHGWDZZQF-UHFFFAOYSA-N ethenyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)C=C NKSJNEHGWDZZQF-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1235—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Salmonella (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nanotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
본 발명은 병원성 식중독, 장관감염을 일으키는 Salmonella를 탐지하는 항체제작 및 Immuno-fluorescent nanoparticle PSQ를 제작하여 신호증폭을 통해 병원성 미생물을 신속하게 검출하는 것이다. The present invention is to rapidly detect pathogenic microorganisms through signal amplification by producing an antibody for detecting Salmonella causing pathogenic food poisoning, intestinal infection and Immuno-fluorescent nanoparticle PSQ.
기존 미생물 검출은 선택배지를 이용한 생물학적 방법, 혈청학적 방법, DNA hybridization assays, PCR(polymerase chain reaction), radio-immunoassay, fluorescence labeled antibody assay, enzyme-link immunosorbent assays(ELISA)등과 같은 많은 immunoassay 기술이 개발되었지만 검출 비용이 고가이고 시간 오래 걸릴 뿐만 아니라, 전처리 과정이 복잡하다(Oh Byung-Keun. 2004 Surface plasmon resonance immunosensor for the detection of Salmonella typhimurium. Biosensors and Bioelectronics. 19:1497-1504.) 또한 Surface plasmon resonance(SPR) 기술은 생체분자간의 상호작용을 측정하는 기술로 잘 알려져 있으며 high specificity과 sensitivity하게 복잡한 생물학적 매체 시료를 짧은 시간에 간단하게 탐색할 수 있는 장점을 갖고 있어 Listeria monocytogenes(Paul Leonard. 2004. A generic approach for the detection of whole Listeria monocytogenes cells in contaminated samples using surface plasmon resonance. Biosensors and Bioelectronics. 19:1331-1335.), Vibrio cholerae O1(Jyoung Jy-Young. 2006. Immunosensor for the detection of Vibrio cholerae O1 using surface plasmon resonance. Biosensors and Bioelectronics. 21:2315-319. ), Salmonella((Oh Byung-Keun. 2004 Surface plasmon resonance immunosensor for the detection of Salmonella typhimurium. Biosensors and Bioelectronics. 19:1497-1504.)) 등의 다양한 병원성 세균 검출에 사용되고 있다. 그러나 SPR방식도 고가의 장비와 숙련된 인력이 필요하다. 이에 형광물질을 이용한 표지면역바이오센서의 미약한 신호량의 개선으로 보다 쉽고 간단한 살모넬라 균주의 검출방법을 개발하고자 하였다. Conventional microbial detection has been developed by many immunoassay technologies such as biological methods, selective serological methods, DNA hybridization assays, polymerase chain reaction (PCR), radio-immunoassay, fluorescence labeled antibody assay, enzyme-link immunosorbent assays (ELISA), etc. Although the detection cost is expensive and time consuming, the pretreatment process is complex (Oh Byung-Keun. 2004 Surface plasmon resonance immunosensor for the detection of Salmonella typhimurium. Biosensors and Bioelectronics. 19: 1497-1504.) (SPR) is a well-known technique for measuring the interaction between biomolecules, and has the advantage of being able to search for high specificity and sensitivity of complex biological media samples in a short time and simply. Listeria monocytogenes (Paul Leonard. 2004. A generic approach for the detection of whole Listeria monocytogenes cells in contaminated samples using surf ace plasmon resonance.Biosensors and Bioelectronics. 19: 1331-1335.), Vibrio cholerae O1 (Jyoung Jy-Young. 2006. ), Salmonella ((Oh Byung-Keun. 2004 Surface plasmon resonance immunosensor for the detection of Salmonella typhimurium. Biosensors and Bioelectronics. 19: 1497-1504.)) Are used for the detection of various pathogenic bacteria. However, the SPR method also requires expensive equipment and skilled personnel. Therefore, we tried to develop a simpler and simpler method of detecting Salmonella strains by improving the weak signal amount of the labeled immune biosensor using fluorescent materials.
Salmonella속 미생물검출에 대한 기존방식은 검출비용의 고가, 긴 소요시간, 전처리과정의 복잡, 숙련된 인력 필요, 낮은 신호량 등 문제점이 있다. 따라서 형광면역바이오센서의 신호증폭기술이 부족한 실태를 해결하고자 한다.Conventional methods for microbial detection of Salmonella have problems such as high detection cost, long lead-time, complexity of pretreatment, skilled manpower, and low signal volume. Therefore, the present invention will solve the lack of signal amplification technology of fluorescent immunosensor.
Salmonella에 대한 특이적 반응을 나타내는 신규의 항체인 Salmonella HilA rabbit polyclonal antibody, Salmonella FliC rabbit polyclonal antibody를 이용한 표지면역 분석방법을 적용할 목적으로 flurorescent dye가 labeling된 항체를 제작된 PSQ nanoparticle에 반응 결합시킨 immuno-fluorescent nanopaticle PSQ를 제작하였다. 바이오면역센서 중 형광면역바이오센서의 적은 신호량을 개선하여 연구원이 아닌 일반인이 병원성 미생물을 쉽고 빠르게 검출할 수 있는 기법을 제시한다. Immunization was performed by immunoreactive binding of a flurorescent dye-labeled antibody to the prepared PSQ nanoparticles for the purpose of applying a labeling immunoassay using Salmonella HilA rabbit polyclonal antibody and Salmonella FliC rabbit polyclonal antibody. -Fluorescent nanopaticle PSQ was prepared. By improving the small signal volume of fluorescent immunosensor among bioimmune sensors, we propose a technique for non-researchers to easily and quickly detect pathogenic microorganisms.
본 발명에서 수행한 Salmonella의 특히 항체인 Salmonella HilA rabbit polyclonal antibody, Salmonella FliC rabbit polyclonal antibody와 결합된 immuno-fluorescent nanoparticle PSQ은 다양한 면역바이오센서와 광면역바이오센서 제작에 유용하게 활용 가능하여, 숙련된 인력과 고가의 기자재의 필요가 없으 며, 대형급식소, 대형백화점, 학교, 군사시설 등에서 병원성 미생물의 존재를 신속하게 검출할 수 있을 것이다.The immuno-fluorescent nanoparticle PSQ combined with Salmonella HilA rabbit polyclonal antibody and Salmonella FliC rabbit polyclonal antibody, which are antibodies of Salmonella performed in the present invention, can be usefully used for the production of various immune biosensors and photoimmune biosensors. There is no need for expensive equipment, and the presence of pathogenic microorganisms can be detected quickly in large catering schools, large department stores, schools, and military facilities.
상기 목적을 달성하기 위하여, 본 발명은 사람에 해를 끼치는 Salmonella에 대한 특이적 반응을 나타내는 항체를 제작하여 병원성 미생물의 존재를 신속하게 검출하는 것을 제공한다.In order to achieve the above object, the present invention provides for the rapid detection of the presence of pathogenic microorganisms by making an antibody showing a specific response to Salmonella harming humans.
<< 실시예Example 1> 항체제작 1> Antibody Production
Salmonella의 Invasion(HilA)와 Flagellin(FliC) 단백질의 peptide 서열에 대한 domain search를 위하여 특이 항원성이 높은 부위의 peptide를 선택하였다. 선택된 peptide region의 hydrophobicity와 antigenecity를 검색하였다. 또한, 본 발명은 Peptide 항원이 항원가가 올라가기 힘들기 때문에 항체가를 상승시키기 위해 carrier 단백질을 결합시켜 면역하였다. carrier로 KLH (Keyhole Limpet Haemocyanin)을 사용하였으며 BSA를 이용하여 결합시켰다. carrier와 결합시킨 peptide를 이용하여 emulsion을 제조하여 면역시켰다. 토끼 1마리당 emulsion 500㎍/0.5㎖씩 피하주사를 시행하였으며, 항원면역반응 측정을 위한 1차, 2차 3차 boosting은 각각 4주, 6주, 8주째에 동일한 항원을 IFA(Incomplete Freund’s adjuvant, Difco, Rockford)와 동일하게 혼합하여 토끼 1마리 당 200㎍/0.5㎖씩 피하주사 하였다. 각 boosting 단계마다 소량의 피를 채취하여 serum을 얻었고, 항체 생성여부 및 titer를 측정하였다. 3차 boosting 1주일 후 전채혈을 하였다. 소량의 피를 채취할 때는 꼬리 끝을 자른 후 피를 채취하며, 전채혈 시에는 심장채혈을 하였다. Peptides with high specific antigenicity were selected for domain search for peptide sequences of Salmonella's Invasion (HilA) and Flagellin (FliC) proteins. The hydrophobicity and antigenecity of selected peptide regions were examined. In addition, the present invention was immunized by binding the carrier protein to increase the antibody titer because Peptide antigen is difficult to rise antigen titer. KLH (Keyhole Limpet Haemocyanin) was used as a carrier and bound using BSA. Emulsions were prepared using peptides conjugated to carriers and immunized. Subcutaneous injection was performed with 500 µg / 0.5 ml of emulsion per rabbit, and the primary and secondary tertiary boosting for the measurement of antigenic immunity were the same antigens at 4, 6 and 8 weeks, respectively, using IFA (Incomplete Freund's adjuvant, Difco, Rockford) was mixed in the same manner and injected by subcutaneous 200μg / 0.5ml per rabbit. A small amount of blood was collected from each boosting step to obtain serum, and antibody production and titer were measured. One week after the third boosting, blood was collected. When a small amount of blood is collected, the tail tip is cut and the blood is collected.
항원의 주사로 유도된 면역반응은 토끼의 혈청에 존재하는 항체의 정도를 ELISA를 수행하여 결정하였다. 항체정제는 항원을 affinity-gel에 부착하여 column을 제작하여 항체를 분리하는 방법과 protein A를 이용한 column 방법을 통하여 정제하였고, 최종적으로 dialysis을 하였다. 그 결과 HilA는 15㎖(1㎎/㎖)를 FliC는 15㎖(10㎎/㎖)를 수획하였다. 제조된 항체는 50% glycerol이 포함된 PBS buffer에 녹여 -20℃에 보관하였고, Salmonella에 특이적으로 반응하는 Ab로 사용하였다. 펩타이드항체 제작과정은 Invasion단백질인 HilA(도1)과 Flagellin 단백질 FliC(도2) 에 나타내었다.The immune response induced by injection of antigen was determined by ELISA to determine the degree of antibody present in rabbit serum. Antibody purification was performed by attaching the antigen to affinity-gel to prepare a column, separating the antibody, and using a column method using protein A. Finally, dialysis was performed. As a result, 15 ml (1 mg / ml) of HilA and 15 ml (10 mg / ml) of FliC were harvested. The prepared antibody was dissolved in PBS buffer containing 50% glycerol and stored at -20 ° C, and used as Ab that specifically reacts with Salmonella. Peptide antibody production process is shown in the Invasion protein HilA (Fig. 1) and Flagellin protein FliC (Fig. 2).
<< 실시예Example 2> 항체의 고정 2> immobilization of antibodies
SPR sensor chip CM5는 유리로 이루어진 판에 50nm의 두께로 금박이 입혀져 있으며 금박부분에는 dextran이 도포되어 있다. 실험재료중 하나는 dextran표면에 고정되어 사용된다. Dextran면은 미세 유로 장치의 flow-cell부분과 접촉하여 유로 장치를 흘러가는 시료와 반응하게 된다. 센서칩 표면의 기종에 따라 둘 또는 네 개의 독립적인 유로 장치의 셀과 접촉하며, 필요에 따라 각 셀 별고 서로 다른 고정화 리간드를 사용하여 다양한 실험을 할 수 있다. 본 실험에서는 일반적으로 사용되는, 용액과 접촉하는 센서칩 표면에는 carboxyl기가 음성 전하를 갖고 있고 dextran은 glucose의 직선형 중합체로서 생체 물질과의 비특이적인 결합이 거의 없고, 용액 중 생체 물질의 농도가 매우 낮아도 매우 효과적으로 리간드를 고정화 할 수 있는 CM5 chip을 사용하여 실험을 했다. 실험에 앞서 최적의 Ab고정화를 위해 10mM Sodium aetate(pH4.5-5.0)을 가지고 preconcentrtion하고 EDC/NHS를 injection하여 Sensor chip 표면을 활성화시켰다. 항체를 10mM sodium acetate(pH5.0)에서 100ug/ml 로 희석하여 1분(5μl/min) 동안 injection 했고. 1M ethanolamine(pH 8.5)으로 미반응 활성기들을 Blocking하고 CM5 chip Ab를 고정화 하였고 고정화 값은 도3 에 나타내었다.SPR sensor chip CM5 is coated with gold leaf on glass plate with 50nm thickness and dextran is applied on the gold leaf part. One of the test materials is used fixed to the dextran surface. The dextran surface is in contact with the flow-cell portion of the microchannel device and reacts with the sample flowing through the channel device. Depending on the model of the sensor chip, the cell contacts the cells of two or four independent flow path devices. If necessary, various experiments can be performed using different immobilized ligands for each cell. In this experiment, the carboxyl group has a negative charge on the surface of the sensor chip which is commonly used in contact with the solution. Dextran is a linear polymer of glucose, which has almost no nonspecific binding to the biological material, and the concentration of the biological material in the solution is very low. The experiment was carried out using a CM5 chip that can immobilize ligand very effectively. Prior to the experiment, the sensor chip surface was activated by preconcentrtion with 10mM sodium aetate (pH4.5-5.0) and injection of EDC / NHS for optimal Ab fixation. The antibody was diluted to 100 ug / ml in 10 mM sodium acetate (pH 5.0) and injected for 1 minute (5 μl / min). Blocking unreacted activators with 1M ethanolamine (pH 8.5) and immobilizing the CM5 chip Ab, the immobilization value is shown in FIG.
<< 실시예Example 3> 3> SalmonellaSalmonella cellcell 과 and HilAHilA , , FliCFliC AgAg 의 농도별 굴절률 변화Refractive Index Variation by Concentration of
Cell과 Ag농도를 PBS beffer에 희석해서 sensor chip surface에 15분(1μl/min)동안 interaction을 했다. 그 결과를 도4(HilA),5(FilC)에 나타내었다. 세포 농도의 변화 및 항원(HilA, FliC) 농도의 변화에 따라 매우 비례적으로 바이오 센서칩이 작용하였다.Cell and Ag concentrations were diluted in PBS beffer to interact with the sensor chip surface for 15 minutes (1 μl / min). The results are shown in Figure 4 (HilA), 5 (FilC). The biosensor chip acted very proportionally with the change of cell concentration and the change of antigen (HilA, FliC) concentration.
<< 실시예Example 4> 4> FluorascentFluorascent nanoparticlenanoparticle PSQPSQ 의 제조Manufacture
Fluorescence-nanoparticle PSQ 제조는 다음과 같다. trithylamine(TEA) 용액에 vinyltrimethoxysilane와 MPTMS를 첨가한 후, 혼합물은 상온에서 magnetic stirring bar를 사용하여 하루 동안 교반하였다. Tween 80을 증류수에서 녹인 후, TEA와 MPTMS는 상온에서 차례로 추가하여 녹였다. PSQ의 전형적인 준비에서는, 1g TEA을 증류수 15에 녹인 후, 1.55g VTMS을 첨가하였다. 혼합물은 하루 동안 교반한 후, 원심분리하였다. 수획된 구체는 50 멸균증류수에 재현탁 하였다. 구체는 물과 메탄올로 2회 세척하여, 4일 동안 50 진공오븐에서 건조하였다(Young Baek kim, 2006). Van Blaaderen 등의 방법으로 PSQ spheres의 rhodamine labeling하였고, Fluorescence-nanoparticle PSQ spheres를 제조하였다(Swadeshmukul Santra, 2001). 도6에 그 결과를 나타내었다.Fluorescence-nanoparticle PSQ preparation is as follows. After adding vinyltrimethoxysilane and MPTMS to the trithylamine (TEA) solution, the mixture was stirred for one day at room temperature using a magnetic stirring bar. After Tween 80 was dissolved in distilled water, TEA and MPTMS were added and dissolved in turn at room temperature. In a typical preparation of PSQ, 1 g TEA was dissolved in distilled water 15 and then 1.55 g VTMS was added. The mixture was stirred for one day and then centrifuged. The harvested spheres were resuspended in 50 sterile distilled water. The spheres were washed twice with water and methanol and dried in 50 vacuum ovens for 4 days (Young Baek kim, 2006). The rhodamine labeling of PSQ spheres was performed by Van Blaaderen et al. And Fluorescence-nanoparticle PSQ spheres were prepared (Swadeshmukul Santra, 2001). The results are shown in FIG.
<< 실시예Example 5> 5> AntibodyAntibody -- labelledlabelled fluorascentfluorascent nanoparticlenanoparticle PSQPSQ 의 제조Manufacture
Antibody-labelled fluorascent nanoparticle PSQ를 제조는 위에서 제조한 Fluorescence-nanoparticle PSQ을 10mM PBS(pH 7.4)에 넣고 bathsonication하였다. 25% glutaraldehyde를 첨가하여 1시간 동안 혼합한 후, 원심분리하고 pH 7.4 PBS buffer로 재 현탁 하였다. Salmonella-rabbit polyclonal Ab(100㎍/㎖) 500㎕를 첨가하여 fluorescence-nanoparticle PSQ spheres에 항체를 고정하였다. 미반응 활성기는 quenching solution(1M ethanolamine, pH 8.5+0.5% BSA)을 넣어 blocking 반응하였다. Antibody-labelled fluorascent nanoparticle PSQ는 도7에 나타내었다.Antibody-labeled fluorascent nanoparticle PSQ was prepared by bathing the fluorescence-nanoparticle PSQ prepared above in 10 mM PBS (pH 7.4). 25% glutaraldehyde was added, mixed for 1 hour, centrifuged and resuspended in pH 7.4 PBS buffer. Antibody was immobilized on fluorescence-nanoparticle PSQ spheres by adding 500 μl of Salmonella-rabbit polyclonal Ab (100 μg / ml). The unreacted activator was blocked by adding a quenching solution (1M ethanolamine, pH 8.5 + 0.5% BSA). Antibody-labeled fluorascent nanoparticle PSQ is shown in FIG.
< 실시예 6> Antibody - labelled fluorascent nanoparticle PSQ 와 Salmonella 특이적 반응 <Example 6> Antibody - labelled fluorascent nanoparticle PSQ and Salmonella specific reactions
미생물과 nanoparticle PSQ의 상호작용을 SEM을 사용하여 분석하였고, sample이 진공상태에서도 같은 형태를 유지하도록 vacuum 상태에서 sensor chip을 건조시켜 관찰했다. 그 결과를 도8에 나타내었다.The interaction between the microorganism and the nanoparticle PSQ was analyzed by SEM, and the sensor chip was dried under vacuum to maintain the same shape in the vacuum. The results are shown in FIG.
도 1는 Salmonella의 Invasion protein(HilA) 펩타이드 항체제작을 위한 과정을 도식화하여 나타낸 것이고,1 is a schematic diagram illustrating a procedure for preparing Salmonella Invasion protein (HilA) peptide antibody,
도 2는 Salmonella의 Flagellin protein(FliC) 펩타이드 항체제작을 위한 과정을 도식화하여 나타낸 것이고,Figure 2 is a schematic diagram showing the process for the manufacture of Salmonella Flagellin protein (FliC) peptide antibody,
도 3는 SPR에 제작한 항체를 고정화시키는 과정을 도식화하여 나타낸 것이고, Figure 3 is a schematic diagram showing the process of immobilizing the antibody produced in SPR,
도 4는 고정화된 HilA 항체에 시료와 반응하는 과정을 도식화하여 나타낸 것이고,4 is a schematic view showing the reaction of the sample with the immobilized HilA antibody,
도 5는 고정화된 FilC 항체에 시료와 반응하는 과정을 도식화하여 나타낸 것이고,5 is a schematic diagram showing the reaction of the sample with the immobilized FilC antibody,
도 6은 제조한 Fluorescent-PSQ을 SEM 결과를 도식화하여 나타낸 것이고,6 is a schematic representation of SEM results of the prepared Fluorescent-PSQ,
도 7은 제조한 Immunofluorescent-PSQ을 SEM 결과를 도식화하여 나타낸 것이고,Figure 7 shows the SEM results of the prepared Immunofluorescent-PSQ,
도 8은 제조한 Immunofluorescent-PSQ와 제작된 항체를 반응시켜 Salmonella와의 특이적인 반응을 도식화하여 나타낸 것이다.Figure 8 shows the reaction of the produced Immunofluorescent-PSQ with the produced antibody, a schematic representation of the specific reaction with Salmonella.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090019720A KR20100101303A (en) | 2009-03-09 | 2009-03-09 | Specific protein domain for the detection of salmonella contamination and manufacture method of its antibody and immuno-fluorescent psq nanoparticle |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090019720A KR20100101303A (en) | 2009-03-09 | 2009-03-09 | Specific protein domain for the detection of salmonella contamination and manufacture method of its antibody and immuno-fluorescent psq nanoparticle |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20100101303A true KR20100101303A (en) | 2010-09-17 |
Family
ID=43006845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090019720A KR20100101303A (en) | 2009-03-09 | 2009-03-09 | Specific protein domain for the detection of salmonella contamination and manufacture method of its antibody and immuno-fluorescent psq nanoparticle |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20100101303A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230085771A (en) * | 2021-12-07 | 2023-06-14 | 한국화학연구원 | Nanomagnetic antibody of Salmonella and the preparation method thereof |
-
2009
- 2009-03-09 KR KR1020090019720A patent/KR20100101303A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230085771A (en) * | 2021-12-07 | 2023-06-14 | 한국화학연구원 | Nanomagnetic antibody of Salmonella and the preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6742978B2 (en) | Signal amplification in lateral flow and related immunoassays | |
Seo et al. | Development of a rapid response biosensor for detection of Salmonella typhimurium | |
AU2010274320B2 (en) | Insulin measurement method | |
KR20120003903A (en) | Method for detecting substance in biological sample | |
CN112940114A (en) | Antifungal 1, 3-beta-D-glucan monoclonal antibody and application thereof | |
US20120064543A1 (en) | Method for detecting substance in biological sample | |
Zhai et al. | Rapid detection of Vibrio parahaemolyticus using magnetic nanobead-based immunoseparation and quantum dot-based immunofluorescence | |
TW201802472A (en) | Anti-human hemoglobin monoclonal antibody or antibody kit, insoluble carrier particle to which anti-human hemoglobin monoclonal antibody is immobilized, and measurement reagent and measurement method using same | |
Huang et al. | Genetically engineered bio-nanoparticles with co-expressed enzyme reporter and recognition element for IgG immunoassay | |
PL316792A1 (en) | Method of detecting presence of mycobacterium species and detecting set therefor as well as correspodning antibodies | |
CN104931685A (en) | Luminescence immune detection method based on recombinant antigen carrying His tag | |
KR20100101303A (en) | Specific protein domain for the detection of salmonella contamination and manufacture method of its antibody and immuno-fluorescent psq nanoparticle | |
WO2016012449A1 (en) | Monoclonal antibody, method, kit and use | |
CN111220802B (en) | Clenbuterol hydrochloride small molecule hapten high sensitivity detection test paper based on nano antibody and preparation method thereof | |
KR20100101248A (en) | Specific protein domain for the detection of listeria contamination and its antibody manufacture method and also their utilization | |
KR101311736B1 (en) | Sandwich immunoassay Biochip and immunoassay method using the same | |
KR100737186B1 (en) | Biosensor for Detection of estriol Having Anti-estriol Antiserum and Detecting Process of estriol | |
KR20100101234A (en) | Specific protein domain for the detection of vibrio contamination and its antibody manufacture method and also their utilization | |
TWI521063B (en) | Biological sensing device and method for separating biomolecule | |
Byzova et al. | Development of immunochromatographic test system for rapid detection of the lipopolysaccharide antigen and cells of the causative agent of bovine brucellosis | |
KR100737246B1 (en) | Biosensor for Detection of Bisphenol-A Having Anti-BPA Antiserum and Detecting Process of Bisphenol-A | |
RU2737776C1 (en) | Test kit for detecting cholera toxin in cultivation medium | |
KR20100101288A (en) | Specific protein domain for the detection of salmonella contamination and its antibody manufacture method and also their utilization | |
Godjevargova et al. | Multiplex fluorescent immunoassay device based on magnetic nanoparticles | |
Byzova et al. | Manufacturing lateral flow tests for tuberculosis diagnosis: choosing a reactants completion and sensing regime |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |